Dr. Mary Solanto is professor of pediatrics and psychiatry at the Hofstra/Northwell School of Medicine (Long Island, N.Y.). Prior to joining Hofstra, she was Director of the ADHD Center at the Mount Sinai School of Medicine and Associate Professor of Psychiatry at NYU. In 2017-2018, Dr. Solanto was a Fulbright U.S. Scholar in the Netherlands, where she conducted research on treatment of ADHD in college students. Dr. Solanto’s research on the cognitive and behavioral functioning of children and adults with ADHD, the effects of psychostimulants, and the characteristics of subtypes of ADHD has been supported by grants from NIMH, NICHD, and NINDS. She developed a novel cognitive-behavioral intervention for adults with ADHD, which was the focus of an NIMH-sponsored efficacy study (American Journal of Psychiatry, 2010). The manual for therapists, Cognitive-Behavioral Treatment of Adult ADHD: Targeting Executive Dysfunction was published by Guilford Press (2011). The program was recognized as the Innovative Program of the Year by CHADD (2011). Dr. Solanto has served on study section/grant review panels for NIMH. Currently, she is a member of the editorial boards of the Journal of Attention Disorders, and the ADHD Report (Guilford Press), and serves on the professional advisory boards of CHADD and APSARD.
Mary V. Solanto, Ph.D.
ADDitude’s Editorial and Medical Review Process
ADDitude is dedicated to publishing quality content that adheres to the highest scientific and editorial standards. Created by qualified writers and medical professionals, our content is fact-checked and reviewed by members of the ADDitude Medical Advisory Panel, including leading clinical practitioners and researchers within the field of ADHD. The ADDitude team adheres to strict editorial standards and journalistic principles. Health information and guidance is thoroughly researched, and sources are vetted to ensure recency, authority, and credibility.
ADDitude editors regularly revisit and update existing content for accuracy and reliability, often in coordination with ADDitude’s Medical Advisory Panel and according to the ADDitude Editorial Process.